ArticleClinical and vaccine immunology : CVI2011

Immunogenicity and safety of a multicomponent meningococcal serogroup B vaccine and a quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135, and Y in adults who are at increased risk for occupational exposure to meningococcal isolates.

Alan Kimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.